Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.14
(
0.02%
)
Bitcoin
78,364.37
(
-0.23%
)
News Focus
News Focus
Post# of 517766
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Amatuer17

Send PM Follow Ignore
Followers 77
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Amatuer17

Re: XenaLives post# 156138

Friday, 07/06/2018 8:47:06 AM

Friday, July 06, 2018 8:47:06 AM

Post# of 517766
Show me

Are you saying that AVXL will not dilute to conduct upcoming P2/3 trial and then P3 trial?
Show me that they can conduct 450 patient multi year trial with current 23 million funds -

Also - is the product approved to go to P3 - heck it is starting P2/3

So what you say is illogical and you cannot refute my statements
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News